Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer
Yu Guo, Min Wang, Yongbo Zou, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 64
Doxorubicin-loaded micelles in tumor cell-specific chemotherapy
Yasir Qasim Almajidi, Mustafa M. Kadhim, Fahad Alsaikhan, et al.
Environmental Research (2023) Vol. 227, pp. 115722-115722
Closed Access | Times Cited: 31
Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis
Yongzhou Huang, Wenchang Yang, Lei Yang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 29
Cancer-associated fibroblasts undergoing neoadjuvant chemotherapy suppress rectal cancer revealed by single-cell and spatial transcriptomics
Pengfei Qin, Huaxian Chen, Yuhang Wang, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 10, pp. 101231-101231
Open Access | Times Cited: 24
STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies
Mehrdad Hashemi, Sahar Abbaszadeh, Mohsen Rashidi, et al.
Environmental Research (2023) Vol. 233, pp. 116458-116458
Closed Access | Times Cited: 20
The expression of exosomal and cellular miRNAs in predicting oxaliplatin resistance in colorectal cancer cells: an in silico and in vitro study
Hoda Deli, Zeynab Vakili-Ghartavol, Yazdan Asgari, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
miRNA-sequencing and bioinformatics analyses of key miRNAs and their associated genes regulated by EC-synthetic retinoids treatment in Caco-2 cancer cells
Hesham Haffez, Ahmed M. Sayed
Gene Reports (2025), pp. 102145-102145
Closed Access
Amphiphilic polymeric nanodrug integrated with superparamagnetic iron oxide nanoparticles for synergistic antibacterial and antitumor therapy of colorectal cancer
Xiaohui Li, Jiazhen Niu, Lingling Deng, et al.
Acta Biomaterialia (2023) Vol. 173, pp. 432-441
Closed Access | Times Cited: 19
Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances
Phanindra Babu Kasi, Venkata Ramana Mallela, Filip Ambrożkiewicz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7922-7922
Open Access | Times Cited: 18
Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer
Yuting Huang, Sze‐Hoi Chan, Shuna Chen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Thermo-responsive composite nanoparticles based on hydroxybutyl chitosan oligosaccharide: Fabrication, stimulus release and cancer therapy
Chong Chen, Weibo Zhang, Pengjie Wang, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 133842-133842
Closed Access | Times Cited: 3
Nanoparticles for imaging-guided photothermal therapy of colorectal cancer
Omid Rahbar Farzam, Niloofar Mehran, Farzaneh Bilan, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21334-e21334
Open Access | Times Cited: 11
Fabrication of curcumin-loaded magnetic PEGylated-PLGA nanocarriers tagged with GRGDS peptide for improving anticancer activity
Fatih Şentürk, Soner Çakmak
MethodsX (2023) Vol. 10, pp. 102229-102229
Open Access | Times Cited: 8
Nano-curcumin formulations for targeted therapy of colorectal cancer
Hossein Shahdadi Sardou, Seyedeh Elnaz Nazari, Mohammadreza Abbaspour, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 88, pp. 104943-104943
Closed Access | Times Cited: 8
V-ATPase Proton Pump May Take Part to Drug-Resistance Phenotype of Glioma Stem Cells
Martina Giambra, Andrea Di Cristofori, Francesca Raimondo, et al.
(2024)
Open Access | Times Cited: 2
Drug repurposing-based nanoplatform via modulating autophagy to enhance chemo-phototherapy against colorectal cancer
Ke Ding, Hailong Tian, Lei Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Monocyte/Macrophage‐Mediated Transport of Dual‐Drug ZIF Nanoplatforms Synergized with Programmed Cell Death Protein‐1 Inhibitor Against Microsatellite‐Stable Colorectal Cancer
Xietao Ye, Yuping Liu, Liangyin Wei, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 2
Chitosan-based hydrogels in cancer therapy: Drug and gene delivery, stimuli-responsive carriers, phototherapy and immunotherapy
Hailin Zhu, Haowei Sun, Jingyuan Dai, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 137047-137047
Closed Access | Times Cited: 2
Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance
Sajad Fakhri, Seyed Zachariah Moradi, Farahnaz Faraji, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 959-1020
Closed Access | Times Cited: 7
Nano-engineering nanomedicines with customized functions for tumor treatment applications
Yuxin Wang, Shimei Li, Xiangling Ren, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Macrophage Migration Inhibitory Factor (MIF) Upregulates CXCR7 and Contributes to Chemotherapy Resistance in Colorectal Cancer
Song Hu, Jiangyi Feng, Weijie Fu, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3437-3452
Closed Access | Times Cited: 1
Challenges in validation of combination treatment strategies for CRC using patient-derived organoids
Valentin Benboubker, George M. Ramzy, S. Jacobs, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Alkaloid from Alstonia yunnanensis diels root against gastrointestinal cancer: Acetoxytabernosine inhibits apoptosis in hepatocellular carcinoma cells
Qi Lai, Chun‐Ju Yang, Qi zhang, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 4
Programmable site-specific delivery of an alkaline phosphatase-activatable prodrug and a mitochondria-targeted cyclopeptide for combination therapy in colon cancer
Huachao Chen, Yongrong Yao, Xing Zhao, et al.
Biomaterials Science (2023) Vol. 11, Iss. 21, pp. 7114-7123
Closed Access | Times Cited: 4
Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer
Shengnan Ren, Zhanyi Zhang, Ruijie Guo, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 13, pp. 1911-1941
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top